|
"kin wei chan"的相關文件
顯示項目 126-132 / 132 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T03:41:32Z |
Preoperative drug dispensing as predictor of surgical site infection
|
Kaye, K.S.;Sands, K.;Donahue, J.G.;Chan, K.A.;Fishman, P.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T03:23:50Z |
Contraindicated use cisapride: Impact of Food and Drug Administration regulatory action
|
Smalley, W.;Shatin, D.;Wysowski, D.K.;Gurwitz, J.;Andrade, S.E.;Goodman, M.;Chan, K.A.;Platt, R.;Schech, S.D.;Ray, W.A.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T03:23:50Z |
Effects of statins [6] (multiple letters)
|
Reynolds, T.M.;Wierzbicki, A.S.;Chan, K.A.; Kin-Wei Chan |
| 臺大學術典藏 |
2014 |
Topiramate use in pregnancy and the birth prevalence of oral clefts
|
Mines, D.;Tennis, P.;Curkendall, S.M.;Li, D.-K.;Peterson, C.;Andrews, E.B.;Calingaert, B.;Chen, H.;Deshpande, G.;Esposito, D.B.;Everage, N.;Holick, C.N.;Meyer, N.M.;Nkhoma, E.T.;Quinn, S.;Rothman, K.J.;Chan, K.A.; Kin-Wei Chan |
| 臺大學術典藏 |
2006 |
Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs
|
Raebel, M.A.;Carroll, N.M.;Simon, S.R.;Andrade, S.E.;Feldstein, A.C.;Lafata, J.E.;Nelson, W.W.;Chan, K.A.;Gunter, M.J.;Tolsma, D.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2005 |
The long-term course of low-density lipoprotein cholesterol after initiation of statin treatment: Retrospective database analysis over 3 years in health maintenance organization enrollees
|
Caspard, H.;Chan, A.K.;Walker, A.M.; Kin-Wei Chan |
| 臺大學術典藏 |
2000 |
Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
|
Chan, K.A.;Andrade, S.E.;Boles, M.;Buist, D.S.M.;Chase, G.A.;Donahue, J.G.;Goodman, M.J.;Gurwitz, J.H.;Lacroix, A.Z.;Platt, R.; Kin-Wei Chan |
顯示項目 126-132 / 132 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
|
